About Us
Protein purification and bioconjugation services are our business. We are noted for expertise in mixed-mode protein chromatography and conjugate vaccines.
Here is what we offer. For more detail, see Protein Services.
- Protein Purification Process Development. We specialize in developing protein purification/downstream processing protocols for laboratory-scale and process scale-up.
- Protein Purification Outsourcing. We can purify your protein for you.
- Bioconjugation chemically links molecules to enhance their biological usefulness. We provide consulting and laboratory bioconjugation services, including bioconjugations for vaccines, immunogens, and diagnostic reagents.
- Conjugate Vaccines. We have decades of experience in conjugate vaccines and proprietary chemistry for preparing carbohydrate conjugate vaccines.
- And More. Through affiliates, we offer protein expression optimization and fermentation services, immunoassay and hybridoma development, and vaccine testing. Our partners include the University of Maryland BioProcessing Scale-up Facility (BSF), the Center for Advanced Research in Biotechnology (CARB) GMP facility, and Antibody and Immunoassay Consultants, LLC.
About Andrew Lees, Scientific Director
Andrew Lees, Ph.D., scientific director and founder of Fina Biosolutions, is an internationally recognized expert in mixed-mode protein chromatography. He consults for Pall Corporation on protein chromatography applications and since 1998 has taught protein chromatography in Europe, India, Singapore, and across the United States.
Additionally he is recognized for his work in conjugate vaccines. One of his inventions underlies the chemistry of GlaxoSmithKline’s pediatric conjugate vaccines Menitorix and Synflorix. Menitorix prevents meningitis caused by Neisseria meningitidis group C or haemophilus influenzae type B. Synflorix, currently under development, will protect against otitis, meningitis, and pneumonia. Currently, Dr. Lees is co-developing conjugate vaccines with the Serum Institute of India.
Dr. Lees is an adjunct faculty member at the Uniformed Services University of the Health Sciences in Bethesda, Maryland and an affiliate of the University of Maryland Bioprocessing Scale-Up Facility. He holds 15 patents and is the author or co-author of more than 40 papers. His Ph.D. in Biophysics is from the Johns Hopkins University.
On his own time Andy indulges a passion for bicycles and delights children with magic tricks at birthday parties.